Meliodays Medical's Pre-Seed Victory: Pioneering a Future of Health Equality for Women's Wellness

Today, Meliodays Medical is proud to share an important update from our latest funding announcement. In a unique reflection of our steadfast commitment to innovation and health equality, we have raised 0 dollars in this recent round. Although external capital did not join us this time around, our forward momentum remains undeterred, powered by our unwavering belief in our mission to revolutionize women’s health. At the heart of our operations is the determination to provide research-backed solutions that address common yet often underestimated conditions such as period pain and dysmenorrhea. This funding milestone, while unconventional, underscores our commitment to reinvesting our internal resources, strategic partnerships, and self-generated revenues to fuel our research and development programs. We see this not as a setback but as an affirmation of our self-reliant approach, which empowers us to focus on what truly matters: creating accessible and effective healthcare solutions for women around the globe. By channeling our efforts into robust clinical research and innovative treatment development, we are paving the way toward a future where health inequality is addressed head-on. Every discovery and every incremental improvement in our products reinforces our belief that even without external funding, our dedicated team can drive meaningful change. We remain excited about the opportunities ahead and are confident that our continued commitment will enable us to build a healthier, more equitable future for women everywhere.